What is the Hims & Hers Health securities class action lawsuit about?

The lawsuit alleges that Hims & Hers Health, Inc. made materially misleading statements about its business operations and prospects during the class period. Specifically, the complaint alleges the company shared consumers' private health information with third-party advertising platforms and charged customers for prescriptions almost immediately after intake form submission, despite representations that patients would first consult with a medical provider.

Who is eligible to join the Hims securities class action?

Investors who purchased or acquired Hims & Hers Health (NASDAQ: HIMS) securities between August 4, 2025 and July 29, 2026 may be eligible to participate in the class action. If you suffered losses on your HIMS investment during this period, you may have the right to seek recovery.

What is the lead plaintiff deadline for the Hims class action lawsuit?

The deadline to apply for lead plaintiff in the Hims & Hers Health securities class action is November 2, 2026. Investors who wish to be considered for the lead plaintiff role must file their motion with the court by this date.

Did Hims & Hers Health allegedly share patients' private health data with advertisers?

The lawsuit alleges that Hims & Hers Health shared consumers' health information with third-party advertising platforms without adequate disclosure. The complaint further alleges this conduct subjected the company to regulatory scrutiny and made it reasonably likely to incur fees and penalties.

What does the Hims lawsuit allege about how the company charges for prescriptions?

The complaint alleges that Hims & Hers Health charges consumers for prescriptions almost immediately after they submit an intake form, despite telling customers they would first be able to consult with a medical provider to find a treatment "right for them." The lawsuit alleges this practice was inconsistent with the company's public representations to consumers about its healthcare model.

What court is handling the Hims & Hers Health securities lawsuit?

The Hims & Hers Health securities class action has been filed in the United States District Court for the Northern District of California. This is the venue where investors seeking to participate or apply for lead plaintiff status would direct their filings.

What regulatory risks does the Hims class action allege the company faced?

The lawsuit alleges that Hims & Hers Health's conduct — including the alleged sharing of consumer health data and its prescription charging practices — subjected the company to regulatory scrutiny. As a result, the complaint alleges the company was reasonably likely to face fees and penalties that were not adequately disclosed to investors.

Why are Hims & Hers Health investors filing a securities fraud lawsuit?

Investors allege that Hims & Hers Health's positive statements about its business, operations, and prospects were materially misleading and lacked a reasonable basis in light of the company's alleged undisclosed practices. The complaint contends that shareholders were harmed when the true nature of these alleged practices and the associated regulatory and financial risks became known.

Hims & Hers Health, Inc. - Faruqi & Faruqi LLP

Hims & Hers Health, Inc.

Join Action

Case Details

Ticker HIMS

Class Period 08/04/2025 - 07/29/2026

Lead Plaintiff Deadline 11/02/2026

Days Left to Seek Lead Plaintiff

If you are a Hims & Hers Health, Inc. investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Hims between August 4, 2025 and July 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NASDAQ: HIMS) and reminds investors of the November 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company shared consumers’ health information with third-party advertising platforms; (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is “right for them;” (3) the foregoing conduct subjected the Company to regulatory scrutiny; (4) as a result of the foregoing, the Company was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Lead Plaintiff Deadline: November 2, 2026

Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310). Or submit your information below to learn about your rights.

Join Action

Hims & Hers Health, Inc.

Monetary Losses ($) *

Website URL

First Name *

Last Name *

Telephone *

Email *

Street Address

City

State

Zip Code

Purchases

1	Purchases Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date
1	Purchases Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date

Add Row

Sales

1	Sales Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date
1	Sales Options Price per Share Date # of Shares Principal Amount Amount Paid Series or Cusip # of Contracts Price per Contract Exercise Price Expiration Date

Add Row

Upload your trades here:

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Select File

Does not establish an attorney-client relationship *

By clicking this box, I acknowledge that this form is not intended to and does not establish an attorney-client relationship between myself and Faruqi & Faruqi LLP, and that the submission or receipt of information via this form, e-mail or telephone does not create an attorney-client relationship.

Case

Users to notify